ROSEANNA BANCROFT: Open Payments
NPI 1942977319 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 42 payments from 11 companies in 2025. Trend: 2023 $1,077 · 2024 $1,027 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $206 |
| AstraZeneca Pharmaceuticals LP | 11 | $196 |
| Amgen Inc. | 5 | $101 |
| Almatica Pharma LLC | 3 | $84 |
| Acella Pharmaceuticals, LLC | 3 | $68 |
| PFIZER INC. | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Exact Sciences Corporation | 2 | $34 |
| ABBVIE INC. | 1 | $28 |
Products named: Rybelsus, REPATHA, FARXIGA, LOREEV XR, NP Thyroid 60, Ozempic, NURTEC ODT, MOUNJARO.
Industry payments across TX — which companies pay providers there.
